The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with major depressive disorder, the company said on Tuesday. The approval paves the way for use of Spravato in patients whose disease has stopped responding to at least two oral anti-depressants.

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year than those who reported no past-year drug use.

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone treatment for adults with major depressive disorder who have not responded to at least two other antidepressants.

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what they've said

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term complications.

Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years.

A paramedic was fired and faces charges after allegedly giving a patient a fatal dose of a paralyzing drug instead of the intended ketamine.

COPS are investigating reports that a man has been handing out vapes laced with spice and ketamine to schoolchildren. Lancashire Police say they are looking into the allegations after three pupils

A now-former Iowa paramedic is facing charges after allegedly giving a man in need the wrong medication — and then failing to act quickly enough to save him.

Lancashire Police are investigating after a man allegedly handed out vapes 'laced with spice and ketamine' at schools.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.